LILRB4 and type 1 diabetes mellitus: TolDCs generated from T1D patients with a suboptimal level of glycated hemoglobin (HbA1c) exhibited down-regulation of immunoregulatory molecules PD-L1 and IL-T3 in comparison with tolDCs prepared from patients with optimal HbA1c level.